Microbial cell membrane phospholipids and associated macromolecular structures

Microbial cell membrane phospholipids and associated macromolecular structures serve as the primary physical and functional barrier for bacteria and fungi, maintaining the electrochemical gradients necessary for ATP synthesis (StatPearls, 2023). These structures are characterized by a high proportion of negatively charged phospholipids, such as phosphatidylglycerol and cardiolipin, which distinguish them from the zwitterionic membranes of mammalian cells (PubMed, PMC3163477). They also encompass essential membrane-associated molecules like Lipid II, which is a critical precursor in peptidoglycan synthesis and a target for several glycopeptide antibiotics (Nature Reviews Microbiology, 2013). Pharmacologically, these membranes are the targets of potent antimicrobial agents like daptomycin and polymyxins, which bind to specific lipid components to induce membrane depolarization or pore formation (NIH, 2022). This disruption leads to the rapid leakage of intracellular ions and cell death, making these structures vital targets for treating severe infections, including those caused by multi-drug resistant pathogens (Journal of Biological Chemistry, 2016). Because the composition of microbial membranes is distinct from human cells, they offer a unique opportunity for selective toxicity in anti-infective drug development.

Other names

Bacterial cytoplasmic membraneFungal plasma membraneMicrobial lipid bilayerBacterial cell membraneProkaryotic membrane

Drugs targeting these structures typically act via physical disruption of the lipid bilayer, formation of transmembrane pores, or sequestration of essential lipid intermediates like Lipid II, leading to loss of membrane potential and leakage of cytoplasmic contents (StatPearls, 2023; PubMed, PMC4324211).